These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23194834)

  • 1. The role of dopamine in inhibitory control in smokers and non-smokers: a pharmacological fMRI study.
    Luijten M; Veltman DJ; Hester R; Smits M; Nijs IM; Pepplinkhuizen L; Franken IH
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1247-56. PubMed ID: 23194834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol modulates midbrain-prefrontal functional connectivity in the rat brain.
    Gass N; Schwarz AJ; Sartorius A; Cleppien D; Zheng L; Schenker E; Risterucci C; Meyer-Lindenberg A; Weber-Fahr W
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1310-9. PubMed ID: 23165219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of reward and punishment on brain activations associated with inhibitory control in cigarette smokers.
    Luijten M; O'Connor DA; Rossiter S; Franken IH; Hester R
    Addiction; 2013 Nov; 108(11):1969-78. PubMed ID: 23773427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonist.
    Luijten M; Veltman DJ; Hester R; Smits M; Pepplinkhuizen L; Franken IH
    Neuropsychopharmacology; 2012 Dec; 37(13):2772-9. PubMed ID: 22850734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go-Nogo and Flanker tasks.
    Lesage E; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
    Neuropsychopharmacology; 2020 Apr; 45(5):857-865. PubMed ID: 31995811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefrontal cortex of adult rats.
    Castillo-Gómez E; Gómez-Climent MA; Varea E; Guirado R; Blasco-Ibáñez JM; Crespo C; Martínez-Guijarro FJ; Nácher J
    Exp Neurol; 2008 Nov; 214(1):97-111. PubMed ID: 18718470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-induced changes in neural network patterns supporting aversive conditioning.
    Diaconescu AO; Menon M; Jensen J; Kapur S; McIntosh AR
    Brain Res; 2010 Feb; 1313():143-61. PubMed ID: 19961836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers.
    Artiges E; Ricalens E; Berthoz S; Krebs MO; Penttilä J; Trichard C; Martinot JL
    Addict Biol; 2009 Sep; 14(4):469-77. PubMed ID: 19650816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of dopamine D₃ receptor neurotransmission in cognition.
    Nakajima S; Gerretsen P; Takeuchi H; Caravaggio F; Chow T; Le Foll B; Mulsant B; Pollock B; Graff-Guerrero A
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):799-813. PubMed ID: 23791072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence.
    Okita K; Mandelkern MA; London ED
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27634830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N2 ERP component as an index of impaired cognitive control in smokers.
    Buzzell GA; Fedota JR; Roberts DM; McDonald CG
    Neurosci Lett; 2014 Mar; 563():61-5. PubMed ID: 24486891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine Enhances Item Novelty Detection via Hippocampal and Associative Recall via Left Lateral Prefrontal Cortex Mechanisms.
    Clos M; Bunzeck N; Sommer T
    J Neurosci; 2019 Oct; 39(40):7920-7933. PubMed ID: 31405927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopamine D2/D3 receptor availability in male smokers.
    Yang YK; Yao WJ; McEvoy JP; Chu CL; Lee IH; Chen PS; Yeh TL; Chiu NT
    Psychiatry Res; 2006 Jan; 146(1):87-90. PubMed ID: 16343861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor ligands for the treatment of tobacco dependence.
    Le Foll B; Goldberg SR; Sokoloff P
    Expert Opin Investig Drugs; 2007 Jan; 16(1):45-57. PubMed ID: 17155853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in "bottom-up" and "top-down" neural activity in current and former cigarette smokers: Evidence for neural substrates which may promote nicotine abstinence through increased cognitive control.
    Nestor L; McCabe E; Jones J; Clancy L; Garavan H
    Neuroimage; 2011 Jun; 56(4):2258-75. PubMed ID: 21440645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.